Initial Infective Agent Of The Disease Anthrax example essay topic

Introduction Since September 11th, terrorism has featured regularly in the media causing widespread alarm. Since the postal attacks in the winter of 2001, in which Bacillus anthracis spores were delivered by mail to targets of terrorism, attention has turned to the possibility of terrorist attack using bio weapons. Bacillus anthracis: The Organism Bacillus anthracis spores, the initial infective agent of the disease anthrax are 1-2 f'Ym by 0.5-1 f'Ym in size (3). Once implanted the spore germinates into the vegetative cell, a gram positive, facultative ly anaerobic bacterium (1). These non-motile vegetative cells are 1-8 f'Ym by 1-1.5 f'Ym in size (2) and secrete three toxin components: lethal factor (LF), oedema factor (ED), and protective antigen (PA) (1) (see fig 1). 1) Bacillus anthracis 2) EF PA LF 3) Anthrax: The Disease and its Treatment The disease is exhibited in three forms in humans.

The most common form is cutaneous anthrax. Spores penetrate the skin via a wound, germinate and cause a temporary disfiguring oedema (7). This is harmless unless the oedema blocks an airway but has been known to lead to anthrax meningitis in some cases (1). The most morbid form is inhalational or pulmonary anthrax, which is fatal in approximately 90% of cases (7).

The third, rarest form of the disease is ingestion al anthrax, which is exhibited gastro-intestinally or oropharyngeally (1). This occurs due to ingestion of meat from an infected animal. This form of the disease is fatal in around 50% of cases (7). The vaccine employed in the USA is an inactivated cell free product, which is 90% effective for 1-2 years. This is currently administered to those in the military and high-risk members of the US postal service (2). B. anthracis is sensitive to a range of antibiotics, such as penicillin, ampicillin, tetracycline, erythromycin, chloramphenicol, oxacillin, streptomycin (8), vancomycin, rifampin, chloramphenicol, imipenem, clindamycin, clarithromycin. Ciproflaxin or doxycycline, along with one or two other antimicrobial agents are administered prophylactively for 100 days after suspected exposure to anthrax (9).

The use of antibiotics has promoted growth of strains resistant to quinol ones (e.g. ciproflaxin) and macrolides (e.g. erythromycin) (10). The value of post exposure vaccine administration has been shown to have positive value as it initiates an immune response (11). The Production and Employment of Bacillus anthracis As a Weapon of Bioterrorism Anthrax was tested in the UK in 1942 when small bombs containing B. anthracis spores were detonated on the surface of the Scottish island of Gruignard. Sheep were tethered near the test sites and number of them died from the pulmonary infection (12).

The soil on the Island remained contaminated up until the early 1980's. Testing of all biological weapons was prohibited under the Biological Weapons and Toxins Convention (1972) signed by most countries including Iraq and the USSR. Iraq went on to weaponize and produce enough anthrax to attack Iran and the Kurdish population (7). An accidental aerosol release of anthrax spores in Sverdlovsk in the former USSR resulted in 79 cases and 68 deaths (13). Some autonomous terrorist organisations are capable of attack using anthrax as a weapon. The Japanese terrorist group Aum Shinrikyo have dispersed aerosols of anthrax throughout Tokyo on numerous occasions but did not succeed in infection (2).

To perform a terrorist attack, a terrorist must first obtain a suitably virulent strain of anthrax, such as the Ames strain of anthrax used in the recent postal attacks. The terrorist may obtain the organism from a number of sources. One possible source would be an infected animal carcass from a region in which the disease is still largely present, such as Iran. The organism must then be cultured on a suitable medium. A medium containing thallous acetate and EDTA is a medium selective for B. anthracis as EDTA chelates an essential cation. B. anthracis can utilise thallous acetate as a replacement while Bacillus cereus (a closely related bacterium) can not (14). Enough B. anthracis spores for a small-scale postal attack (only a few litres) may be cultured in a regular kitchen (7).

To cause inhalational anthrax, the product must be milled into a fine enough powder to become airborne on opening of the package at its destination. Weapons-grade anthrax, which is milled into a very fine powder, absent of the sticky material difficult to eliminate with only basic equipment, may be obtained by theft from research installations, or purchased from a rogue nation such as Iraq or rogue elements within a nation such as the Russian Mafia. A large-scale terrorist attack would be extremely difficult but not impossible. Detection by the authorities must be avoided, sufficient funding must be found. Getting the spores airborne is also difficult, as security regarding the procurement of an aeroplane for any purpose has tightened. Also, meteorology must be considered.

Airborne spores may not travel upwind. High humidity decreases the time for which the spores remain airborne (13). If 100 kg of anthrax was released over Washington DC, the 130,000 to 3 million fatal cases are predicted. This matches the effects of a hydrogen-bomb attack (2). Escherichia coli has been cloned containing the plasmid encoding the lethal anthrax-toxin components. They produced less toxin than B. anthracis and did not excrete the product (14).

This technique could be employed to produce large amounts of lethal toxin for felonious uses. Other organisms could be investigated as more suitable candidates for genetic manipulation to produce the toxin. Anthrax Compared with other Possible Agents of Bioterrorism Infective Agent. Predicted number of persons infected.

Predicted number of persons killed. Anthrax (Bacillus anthracis) spores 250 000 100 000 Plague (Yersinia pestis) bacteria 150 000 36 000 Tularemia (Fracisella tularensis) bacteria 250 000 19 000 A number of other organisms or biologically derived substances may be considered as potential agents of bioterrorism. Smallpox causing variola virus is possibly the most feared of these. The disease is extremely infectious. The infectious dose is only a few virions (15), while 2500 to 55000 inhaled anthrax spores are required to cause pulmonary anthrax (2).

Secondary transmission of smallpox is possible via contact or droplet-infection (15), while anthrax finds a biological! SS dead-end!" in humans (1). There is also no safe treatment for smallpox. Vis tide (cidofovir) is thought to be useful but its use promotes renal failure (16). Once contracted, smallpox is around 30% fatal, while pulmonary anthrax is around 90% fatal once infected.

Anthrax spores are also more persistent in the environment. Smallpox is also very difficult to obtain as it only remains in two laboratories in the world, one in the USA, one in Novosibirsk in Russia (16). It is alleged that Russia has produced and weaponized smallpox for use in ballistic missiles (15). Botulinum toxin is another agent employed by the Aum Shinrykyo group in its attacks around Tokyo (2). Derived from Clostridium botulinum, an easily obtainable, soil-dwelling bacterium, it is the most poisonous substance known to humankind.

The lethal inhaled dose is less than 1 f'Yg. An aerosol release is predicted to kill 10% of people to 0.5 km downwind. Iran, Iraq, Syria and North Korea have weaponized botulism toxin (17). Yersinia pestis causes potentially fatal pneumonic plague.

Secondary spread is possible, as in smallpox. There is no vaccine available against Y. pestis and some antibiotic-resistant strains exist (18). Francis ella tularensis is one of the most infectious known bacteria. It causes tularemia, which is fatal to a lesser extent than inhalational anthrax (19) (as shown in table 1) Conclusion B. anthracis is indeed a potentially potent weapon of bioterrorism. Each agent of bioterrorism mentioned above has factors such as availability, infectivity, incidence of secondary infection, and fatality of the disease. Anthrax compensates for its relatively low infectivity and lack of secondary infection, by its availability, the fatality of the disease, and the persistence of the spore in the environment, which can be up to sixty years in soil (20).

None of the other organisms mentioned persist in the environment for any significant length of time. The widespread panic among civilians and costs to the USA government in prevention (tightened security, development and production of vaccines and antibiotics) is the first significant victory to potential bio terrorists. As terrorist organisations grow (even some countries, such as Iraq, are regarded as! yen terrorist states! |) the threat of large-scale attack, using anthrax as a bio weapon, grows concomitantly. Word Count: 1222 words

Bibliography

1. Quinn CP, Turnbull PCB. In: Top ley and Wilson's Microbiology and Microbial Infections, volume 3; 1998.
p 799-815 2. Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax as a Biological Weapon. JAMA 1999;
281: 1735-1745 3. Gerhardt P. Cytology of Bacillus anthracis. Fed Proc 1967;
26: 1504-1517 4. Tang G, Lep pla SH. Proteasome Activity is Required for Anthrax Lethal Toxin to Kill Macrophages. Infect and Immun 1999;
67: 3055-3060 5. Price LB, Hugh-Jones M, Jackson PJ, Kim P. Genetic Diversity in the Protective Antigen Gene of Bacillus anthracis. J Bacteriol 1999;
181: 2358-2362 6. Welk os SL, Viet ri NJ, Gibbs PH. Non-toxigenic Derivatives of the Ames Strain of Bacillus anthracis are Fully Virulent for Mice: role of Plasmid pX 02 and Chromosome in Strain- dependent Virulence. Micro Pathogen 1993;
14: 381-388 7. Ala! |Aide en D. Risk of Deliberately Induced Anthrax Outbreak. Lancet 2001;
358: 1386-1388 8. Nalin DR, Sultana B, Sahunja R et al. Survival of a Patient with Intestinal Anthrax. Am J Med 1977;
62: 130-132 9. Malecki J, Wier sma S, Cahill K et al. Investigation of Bioterrorism-Related Anthrax and Interim Guidelines for Exposure Management and Antimicrobial Therapy. JAMA 2001;
286: 2226-2232 10. Stephenson J. Experts Focus on Infective Agents of Bioterrorism JAMA 2002;
287: 575-576 11. Centres for Disease Control and Prevention. Additional Options for Preventive Treatment for Persons Exposed to Inhalational Anthrax. JAMA 2002;
287: 579 12. Manche e RJ, B roster J, M elling J et al. Bacillus anthracis on Gruignard Island. Nature 1981;
294: 254-255 13. Mes elson M, Guillemin J, Hugh-Jones M et al. The Sverdlovsk Anthrax Outbreak of 1979.
Science 1994;
266: 1202-1208 14. Knisely RF. Selective Medium for Bacillus anthracis. J Bacteriol 1966;
92: 785-786 15. Henderson DA, Inglesby TV, Bartlett JG et al. Smallpox as a Biological Weapon. JAMA 1999;
281: 2127-2137 16. Kun in A. Bioterrorism and your skin. web 17. Arn on SS, Schechter R, Inglesby TV et al. Botulinum Toxin as a Biological Weapon JAMA 2001;
285: 1059-1070 18. Inglesby TV, Dennis DT, Henderson DA et al. Plague as a Biological Weapon JAMA 2000;
283: 2281-2290 19. Dennis DT, Inglesby TV, Henderson DA et al. Tularemia as a Biological Weapon JAMA 2001;
285: 2763-2773 20. Wilson JB, Russell KE. Isolation of Bacillus anthracis from soil stored 60 years. J Bacteriol 1964;